Development of Novel Fast GPU Monte Carlo and Active Photonics Simulation Softwar

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43CA183236-01A1
Agency Tracking Number: R43CA183236
Amount: $225,000.00
Phase: Phase I
Program: SBIR
Awards Year: 2014
Solicitation Year: 2014
Solicitation Topic Code: NCI
Solicitation Number: PA13-234
Small Business Information
SIMPHOTEK, INC.
211 Warren Street, Newark, NJ, 07103-3568
DUNS: 800606860
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 MARY POTASEK
 (609) 468-9291
 mpotasek@simphotek.com
Business Contact
 KARL BEESON
Phone: (609) 468-9291
Email: beesonk@simphotek.com
Research Institution
 Stub
Abstract
DESCRIPTION (provided by applicant): Photodynamic therapy (PDT) is used for treating a variety of medical conditions including cancer. Even after many years of PDT research and the large-scale use of PDT treatments by physicians, there are many aspects ofPDT, such as quantitative predictions for diffusive light propagation and the kinetics of the light-material interactions, that are not well understood. This can lead to a large variation in treatment results In particular, the dosimetry for treatments ischallenging and it is difficult to determine the lasr light energies and the photosensitizer (PS) concentrations that are optimal. In this Phase I SBIR, Simphotek (prime institution), Tech-X (subaward institution) and University of Pennsylvania School of Medicine, i.e. UPenn (subaward institution) will investigate the feasibility of experimentally (UPenn) and computationally (Simphotek/Tech-X) guiding novel and easy-to-use mathematical and numerical methods for PDT. The software product(s) that result

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government